Antiviral Drugs Market
According to Intent Market Research, the Antiviral Drugs Market is expected to grow from USD 57.4 billion in 2023 at a CAGR of 5.8% to touch USD 85.1 billion by 2030. The Antiviral Drugs Market is dominated by key players such as Gilead Sciences, Inc., Merck & Co., Inc., Johnson & Johnson, AbbVie Inc., GlaxoSmithKline Plc, Bristol-Myers Squibb Company, Roche Holding AG, Pfizer Inc., Novartis International AG, Boehringer Ingelheim, Sanofi S.A., Eli Lilly and Company, Takeda Pharmaceutical Company, Astellas Pharma Inc., Cipla Limited.